Tom Brophy Sells 380 Shares of Croda International Plc (LON:CRDA) Stock

Croda International Plc (LON:CRDA) insider Tom Brophy sold 380 shares of the business’s stock in a transaction dated Monday, April 7th. The stock was sold at an average price of GBX 2,643 ($34.07), for a total transaction of £10,043.40 ($12,945.86).

Croda International Stock Performance

Shares of LON CRDA traded down GBX 158 ($2.04) during midday trading on Monday, reaching GBX 2,596 ($33.46). The company’s stock had a trading volume of 1,154,314 shares, compared to its average volume of 1,838,898. The firm has a 50 day moving average price of GBX 3,128.82 and a 200-day moving average price of GBX 3,442.18. The stock has a market capitalization of £3.63 billion, a P/E ratio of 22.31, a PEG ratio of 1.40 and a beta of 0.74. Croda International Plc has a 12-month low of GBX 2,567 ($33.09) and a 12-month high of GBX 5,034 ($64.89). The company has a debt-to-equity ratio of 30.90, a current ratio of 2.72 and a quick ratio of 2.25.

Croda International (LON:CRDA) last announced its quarterly earnings data on Tuesday, February 25th. The company reported GBX 142.60 ($1.84) EPS for the quarter. Croda International had a net margin of 9.98% and a return on equity of 6.96%. As a group, equities analysts predict that Croda International Plc will post 181.8307268 earnings per share for the current year.

Croda International Increases Dividend

The firm also recently disclosed a dividend, which will be paid on Wednesday, May 28th. Shareholders of record on Thursday, April 10th will be issued a dividend of GBX 63 ($0.81) per share. The ex-dividend date is Thursday, April 10th. This is an increase from Croda International’s previous dividend of $47.00. This represents a yield of 2.03%. Croda International’s dividend payout ratio is 93.66%.

About Croda International

Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world.